Who owns Jazz Pharmaceuticals plc (JAZZ)? Elite investor 13F holders
7 tracked elite investors reported holding Jazz Pharmaceuticals plc as of 2026-06-30, including Renaissance Technologies LLC, D.E. Shaw, Gotham Asset Management, Aristotle Capital Management, Tweedy Browne. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
7 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences
Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally. The company offers Xywav to treat cataplexy or excessive daytime sleepiness (EDS) with narcolepsy and idiopathic hypersomnia (IH); Epidiolex for seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), or tuberous sclerosis complex…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| Renaissance Technologies LLC | JAZZ PHARMACEUTICALS PLC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 135442731.00 USD | 562073.000000 | Shares | reduce | Original filing |
| D.E. Shaw | JAZZ PHARMACEUTICALS PLC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 20982463.00 USD | 87075.000000 | Shares | reduce | Original filing |
| Gotham Asset Management | JAZZ PHARMACEUTICALS PLC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 26992014.00 USD | 112014.000000 | Shares | add | Original filing |
| Aristotle Capital Management | JAZZ PHARMACEUTICALS PLC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 26915626.00 USD | 111697.000000 | Shares | reduce | Original filing |
| Tweedy Browne | JAZZ PHARMACEUTICALS PLC | SHARE | 2026-06-30 | 2026-08-07 00:00:00 | 14494105.00 USD | 60149.000000 | Shares | reduce | Original filing |
| Oaktree Capital Management | JAZZ PHARMACEUTICALS PLC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 0.00 USD | 0.000000 | Principal | exited | Original filing |
| Polen Capital Management | JAZZ PHARMACEUTICALS PLC | SHARE | 2026-06-30 | 2026-08-04 00:00:00 | 447722.00 USD | 1858.000000 | Shares | buy | Original filing |
| Ancora Advisors / Ancora Holdings | JAZZ PHARMACEUTICALS PLC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 8193.00 USD | 34.000000 | Shares | reduce | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.